Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
Go back to Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial| (NASDAQ: CMND) | Delayed: 0.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.80 | 52 Week High | $ | |||
| Open | $0.80 | 52 Week Low | $ | |||
| Day High | $0.80 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $ | |||
| Volume | 10,187 | |||||
